FOENIX-CCA2: A phase II, open-label, multicenter study of futibatinib in patient
- This topic has 0 replies, 1 voice, and was last updated 3 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
FOENIX-CCA2: A phase II, open-label, multicenter study of futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 gene fusions or other rearrangements.
https://meetinglibrary.asco.org/record/186878/abstract
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.